RYVU THERAPEUTICS ZY-,40/ PLSELVT00013 /
| 15/11/2024 19:31:22 | Chg. -0.420 | Volume | Bid20:03:44 | Ask20:03:44 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 10.000EUR | -4.03% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 243.13 mill.EUR | - | - |
Assets
|
2021 IFRS in th. PLN |
2022 IFRS in th. PLN |
2023 IFRS in th. PLN |
||||
|---|---|---|---|---|---|---|---|
| Property and Equipment | 87,876 | 80,346 | 76,517 | ||||
| Intangible Assets | 3,044 | 4,276 | 1,038 | ||||
| Long-Term Investments | 29,404 | 20,475 | 16,904 | ||||
| Fixed Assets | 124,565 | 107,047 | 124,809 | ||||
| Inventories | 1,957 | 1,759 | 2,118 | ||||
| Accounts Receivable | 11,741 | 16,931 | 32,837 | ||||
| Cash and Cash Equivalents | 83,236 | 101,917 | 57,939 | ||||
| Current Assets | 104,248 | 367,930 | 278,393 | ||||
| Total Assets | 228,813 | 474,977 | 403,202 | ||||
Liabilities
|
2021 IFRS in th. PLN |
2022 IFRS in th. PLN |
2023 IFRS in th. PLN |
||||
|---|---|---|---|---|---|---|---|
| Accounts Payable | 20,915 | 15,499 | 27,433 | ||||
| Long-term debt | 742 | 0.0000 | 8,854 | ||||
| Liabilities to Banks | - | - | - | ||||
| Provisions | - | - | 432 | ||||
| Liabilities | 67,512 | 131,586 | 143,610 | ||||
| Share Capital | - | - | - | ||||
| Total Equity | 161,302 | 343,390 | 259,592 | ||||
| Minority Interests | - | - | - | ||||
| Total liabilities equity | 228,813 | 474,977 | 403,202 | ||||
Income Statement
|
2021 IFRS in th. PLN |
2022 IFRS in th. PLN |
2023 IFRS in th. PLN |
||||
|---|---|---|---|---|---|---|---|
| Revenues | 35,413 | 68,437 | 67,296 | ||||
| Depreciation (total) | 12,561 | 12,900 | 10,971 | ||||
| Operating Result | - | -78,422 | -100,948 | ||||
| Interest Income | -363 | -773 | 8,836 | ||||
| Income Before Taxes | - | - | - | ||||
| Income Taxes | 116 | 4,587 | - | ||||
| Minority Interests Profit | - | - | - | ||||
| Net Income | -79,078 | -83,782 | -92,112 | ||||
Per Share
Cash Flow
|
2021 IFRS in th. PLN |
2022 IFRS in th. PLN |
2023 IFRS in th. PLN |
||||
|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -58,886 | 21,319 | -84,550 | ||||
| Cash Flow from Investing Activities | 8,055 | 690 | -195,541 | ||||
| Cash Flow from Financing | -2,152 | -2,455 | 240,833 | ||||
| Decrease / Increase in Cash | - | - | - | ||||
| Employees | 186 | 198 | - | ||||
